Avner Halperin

Avner Halperin is a fellow at the Middle East Initiative. He is an entrepreneur, executive and researcher in digital health, AI and technology policy.  He serves as CEO of Sheba Impact – the commercialization and entrepreneurship arm of Sheba Medical Center.  In this position, he leads the creation of dozens of breakthrough medical technology startups and the building of a vibrant startup ecosystem around Sheba valued at over $4.2 Billion.  In addition, he is Chairman of the Board at EyeControl Ltd. - an AI based medical device company that won the Genesis Award for contribution to the battle again COVID-19.

Previously, he was the founding CEO of EarlySense, a medical technology startup that developed a contactless sensor that became the standard of care in well over 1,000 US hospitals.  This technology was acquired by Baxter International.  Earlier, he was VP Marketing at Radcom (NASDAQ: RDCM) and R&D leader at Eldat (acquired by Pricer).

Avner earned an M.Sc. in Applied Physics from Tel Aviv University and an MBA from MIT where he researched the operations of globally dispersed teams.  He is a lecturer at Tel Aviv University where he teaches a course on Big Data and AI Economics.  In 2019, he gave a TED talk on AI in Healthcare.  He is also an inventor with 34 US Patents.